5PSQ-092 Analysis of off-label uses of inhalers in hospitalised patients

摘要

The high prevalence of respiratory diseases leads to high consumption of inhaled bronchodilators (IBs) not always appropriately indicated. It is important for patients and for the healthcare systems that a proper indication and use not only achieves greater efficacy and adherence to the treatment, but also because of the high economic impact of these medications.